Cargando…

Apolipoprotein A1 in Cerebrospinal Fluid Is Insufficient to Distinguish Alzheimer’s Disease from Other Dementias in a Naturalistic, Clinical Setting

Apolipoprotein A1 (ApoA1) is the major protein component of the high-density lipoprotein and involved in cholesterol transport. Disruption of cholesterol homeostasis has been identified as a contributing factor for Alzheimer’s disease (AD). Moreover, polymorphisms of ApoA1 have been associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stoye, Nicolai Maximilian, Jung, Patrick, Guilherme, Malena dos Santos, Lotz, Johannes, Fellgiebel, Andreas, Endres, Kristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2020
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081088/ https://www.ncbi.nlm.nih.gov/pubmed/32206754 http://dx.doi.org/10.3233/ADR-190165

Ejemplares similares

The Synthetic Retinoid Acitretin Increases IL-6 in the Central Nervous System of Alzheimer Disease Model Mice and Human Patients
por: dos Santos Guilherme, Malena, et al.
Publicado: (2019)

Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma
por: Koch, Manja, et al.
Publicado: (2017)

Cerebrospinal Fluid Apolipoprotein E Levels in Delirium
por: Caplan, Gideon A., et al.
Publicado: (2017)

Impact of the Age of Cecal Material Transfer Donors on Alzheimer’s Disease Pathology in 5xFAD Mice
por: Valeri, Francesco, et al.
Publicado: (2021)

Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients
por: Lennol, Matthew Paul, et al.
Publicado: (2022)

Influence of Acetylcholine Esterase Inhibitors and Memantine, Clinically Approved for Alzheimer’s Dementia Treatment, on Intestinal Properties of the Mouse
por: Nguyen, Vu Thu Thuy, et al.
Publicado: (2021)

Cerebrospinal fluid catecholamines in delirium and dementia
por: Henjum, Kristi, et al.
Publicado: (2021)

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms
por: Wahrle, Suzanne E, et al.
Publicado: (2007)

Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer’s pathology
por: Hu, Hao, et al.
Publicado: (2020)

The Role of Cerebrospinal Fluid Biomarkers in Dementia and Other Related Neurodegenerative Disorders
por: Paraskevas, George P.
Publicado: (2022)

Apolipoprotein A1, the neglected relative of Apolipoprotein E and its potential role in Alzheimer’s disease
por: Endres, Kristina
Publicado: (2021)

CXCL11 production in cerebrospinal fluid distinguishes herpes simplex meningitis from herpes simplex encephalitis
por: Lind, Liza, et al.
Publicado: (2017)

Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies
por: Mukaetova-Ladinska, Elizabeta B., et al.
Publicado: (2010)

Cerebrospinal Fluid Hypocretin and Nightmares in Dementia Syndromes
por: Trotti, Lynn Marie, et al.
Publicado: (2021)

Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases
por: Iriyama, Chisako, et al.
Publicado: (2023)

Identification of Patulin from Penicillium coprobium as a Toxin for Enteric Neurons
por: Brand, Benjamin, et al.
Publicado: (2019)

Increased Prothrombin, Apolipoprotein A-IV, and Haptoglobin in the Cerebrospinal Fluid of Patients with Huntington's Disease
por: Huang, Yen-Chu, et al.
Publicado: (2011)

Cerebrospinal fluid biomarkers for Alzheimer’s disease: the role of apolipoprotein E genotype, age, and sex
por: Mehrabian, Shima, et al.
Publicado: (2015)

Cerebrospinal fluid markers to distinguish bacterial meningitis from cerebral malaria in children
por: Njunge, James M., et al.
Publicado: (2017)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

Cerebrospinal fluid analysis in individuals with diabetes-related dementia
por: Kanetaka, Hidekazu, et al.
Publicado: (2017)

Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
por: Ljubenkov, Peter A., et al.
Publicado: (2018)

Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies
por: Foska, Aikaterini, et al.
Publicado: (2022)

Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
por: Foulds, P.G., et al.
Publicado: (2012)

Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases
por: Minta, K., et al.
Publicado: (2020)

Cerebrospinal fluid biomarkers and apolipoprotein E genotype in cerebral amyloid angiopathy. A narrative review
por: Theodorou, Aikaterini, et al.
Publicado: (2021)

Chronic Cerebrospinal Venous Insufficiency
por: Rasman, Alessandro
Publicado: (2015)

Psychobiological Evaluation of Day Clinic Treatment for People Living With Dementia – Feasibility and Pilot Analyses
por: Wuttke-Linnemann, Alexandra, et al.
Publicado: (2022)

Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses
por: Räuber, Saskia, et al.
Publicado: (2021)

Integrating host transcriptomic signatures for distinguishing autoimmune encephalitis in cerebrospinal fluid by metagenomic sequencing
por: Fan, Siyuan, et al.
Publicado: (2023)

Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels
por: Bloniecki, Victor, et al.
Publicado: (2014)

VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
por: van Steenoven, Inger, et al.
Publicado: (2019)

Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis
por: Perga, Simona, et al.
Publicado: (2015)

Protein signature in cerebrospinal fluid and serum of Alzheimer’s disease patients: The case of apolipoprotein A-1 proteoforms
por: Fania, Chiara, et al.
Publicado: (2017)

Increased apolipoprotein E and decreased TNF‐α in the cerebrospinal fluid of nondemented APOE‐ε4 carriers
por: Sasayama, Daimei, et al.
Publicado: (2020)

Elevated Free Phosphatidylcholine Levels in Cerebrospinal Fluid Distinguish Bacterial from Viral CNS Infections
por: Al-Mekhlafi, Amani, et al.
Publicado: (2021)

Dietary Wheat Amylase Trypsin Inhibitors Impact Alzheimer’s Disease Pathology in 5xFAD Model Mice
por: dos Santos Guilherme, Malena, et al.
Publicado: (2020)

Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS)
por: Saunders, Tyler S., et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease
por: Sweeney, Melanie D, et al.
Publicado: (2015)

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
por: Alexopoulos, Panagiotis, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5b3qjj8udnvgef6a5a1pjldqn9